Scarica l'app Stockscreener
12.42
2.60%
0.315
Dopo l'orario di chiusura:
12.42
Precedente Chiudi:
$12.11
Aprire:
$11.99
Volume 24 ore:
85,551
Relative Volume:
0.50
Capitalizzazione di mercato:
$510.43M
Reddito:
-
Utile/perdita netta:
$-32.74M
Rapporto P/E:
-7.9018
EPS:
-1.5718
Flusso di cassa netto:
$-24.89M
1 W Prestazione:
-14.81%
1M Prestazione:
-0.80%
6M Prestazione:
+6.15%
1 anno Prestazione:
+90.78%
Intervallo 1D:
$11.99
$12.68
Intervallo di 1 settimana:
$11.69
$14.82
Portata 52W:
$5.765
$16.94
Third Harmonic Bio Inc Stock (THRD) Company Profile
Nome
Third Harmonic Bio Inc
Settore
Industria
Telefono
(209) 727-2457
Indirizzo
1700 MONTGOMERY STREET, SAN FRANCISCO
Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-12-16 | Downgrade | Jefferies | Buy → Hold |
| 2022-12-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-10 | Iniziato | Cowen | Outperform |
| 2022-10-10 | Iniziato | Jefferies | Buy |
| 2022-10-10 | Iniziato | Morgan Stanley | Overweight |
Third Harmonic Bio Inc Borsa (THRD) Ultime notizie
(THRD) Technical Data - Stock Traders Daily
Third harmonic bio sees $14.3 million in stock sales by BVF Partners - Investing.com India
Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive
Third Harmonic Bio's chief medical officer sells $40,095 in stock - Investing.com
A new biotech, built around protein design, springs from David Baker’s lab - BioPharma Dive
Where are the Opportunities in (THRD) - Stock Traders Daily
(THRD) Trading Signals - Stock Traders Daily
Upstream prices $255M IPO in bid to challenge Amgen, AstraZeneca asthma drug - BioPharma Dive
Startup led by John Maraganore raises $135M to build ‘future of RNAi’ - BioPharma Dive
Third Harmonic Bio: Nothing Stands Out (NASDAQ:THRD) - Seeking Alpha
Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney - BioPharma Dive
How To Trade (THRD) - Stock Traders Daily
Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise By Investing.com - Investing.com South Africa
Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise - Investing.com
WAVE Life Sciences (NASDAQ:WVE) Stock Quotes, Forecast and News Summary - Benzinga
Long Term Trading Analysis for (THRD) - Stock Traders Daily
Third Harmonic Bio executive sells shares worth over $71,000 - Investing.com India
Third harmonic bio executive sells over $140k in stock By Investing.com - Investing.com South Africa
Third Harmonic Bio executive sells shares worth over $71,000 By Investing.com - Investing.com Australia
Third harmonic bio executive sells over $140k in stock - Investing.com
Victory Capital Management Inc. Has $1.14 Million Position in Hamilton Lane Incorporated (NASDAQ:HLNE) - Defense World
Highbridge Capital Management LLC Purchases Shares of 630,114 HashiCorp, Inc. (NASDAQ:HCP) - MarketBeat
How the (HRMY) price action is used to our Advantage - Stock Traders Daily
Hyliion Holdings Corporation [HYLN] Records 50-Day SMA of $2.01 - Knox Daily
23andMe faces Nasdaq delisting - MSN
Independent directors resign from 23andMe board after opposing move to privatize - Washington Times
23andMe Stock Falls as All Board Members Resign - Barron's
Finnish Authorities Are After Hex And PulseChain Founder, Richard Heart On Suspicion Of Tax Evasion And Assault - 99Bitcoins
Third Harmonic Bio Inc (THRD) Stock: A Comprehensive 52-Week Review - The InvestChronicle
ME STOCK ALERT: 23andMe Holding Co. Shareholders are - GlobeNewswire
23andme board resigns : Turmoil at 23andMe: Board Resigns Amid Controversial Plans to Go Private - CGNEWS24
23andme board resigns : 23andMe Board Resigns En Masse: A Fatal Blow to the DNA Testing Giant? - CGNEWS24
Rhumbline Advisers Boosts Holdings in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World
Hex And PulseChain Founder Richard Heart In Hot Water With Finnish Authorities - Cryptonews
23andMe Board Resigns in New Blow to DNA-Testing Company and CEO Anne Wojcicki - The Wall Street Journal
Crypto Influencer Richard Heart Investigated for Tax Evasion - Crypto Times
23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private - New York Post
Check Out Hyliion Holdings Corporation (HYLN)’s Trade Data Rather Than the Analysts’ Views - SETE News
A Look at Harmonic, Inc. (HLIT) Shares in the Recent Past Indicates Growth - SETE News
Finnish Police Seeking Hex Founder Richard Heart for Suspected Gross Tax Evasion, Assault - Decrypt
Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time - Yahoo Finance
23andMe’s stock tumbles 7% after independent directors quit in clash with CEO over buyout plan - MarketWatch
23andMe Shares Fall After Independent Directors Resign Amid Spat Over Buyout Bid - MarketWatch
23andMe down after independent directors quit board - XM
Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits - BNN Bloomberg
Raymond James analysts upgrades a Strong buy rating for Harmonic, Inc. (HLIT) - Knox Daily
Nura Bio gets $68M, new CEO to advance ‘neuroprotective’ brain drugs - BioPharma Dive
Hyliion Holdings Corporation (HYLN) did well last session? - US Post News
HashiCorp Inc (HCP) Becoming More Attractive for Investors - Knox Daily
Third Harmonic Bio (NASDAQ:THRD) Is In A Strong Position To Grow Its Business - Yahoo Finance
Commonwealth Equity Services LLC Trims Stake in Haleon plc (NYSE:HLN) - Defense World
Third Harmonic Bio Inc Azioni (THRD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Third Harmonic Bio Inc Azioni (THRD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Conner Edward R. | Chief Medical Officer |
Oct 28 '24 |
Option Exercise |
4.20 |
2,673 |
11,227 |
2,673 |
| Conner Edward R. | Chief Medical Officer |
Oct 28 '24 |
Sale |
15.00 |
2,673 |
40,095 |
0 |
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):